What is Neurocrine Biosciences's revenue?

Neurocrine Biosciences (NBIX) generated $3.1B in revenue over the trailing twelve months, up 28.6% year over year.

Is Neurocrine Biosciences profitable?

Neurocrine Biosciences reported $668.6M in net income over the trailing twelve months, a 21.6% net margin.

What are Neurocrine Biosciences's profit margins?

Gross margin is 98.2% and operating margin is 25.4%, with a 21.6% net margin.

What is Neurocrine Biosciences's earnings per share?

Neurocrine Biosciences's diluted EPS over the trailing twelve months is $6.49.

Where does Neurocrine Biosciences's income statement data come from?

Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Neurocrine Biosciences NBIX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$3.1B+28.6%	$2.86B+21.4%	$2.68B+19.6%	$2.51B+18.4%	$2.41B+21.7%
Total cost of revenue	$56.7M+58.8%	$52.1M+53.2%	$43.8M+31.9%	$37.8M+3.8%	$35.7M-7.8%
Gross profit	$3.05B+28.1%	$2.81B+21.0%	$2.64B+19.4%	$2.47B+18.7%	$2.38B+22.3%
Gross margin	98.2%-0.3pp	98.2%-0.4pp	98.4%-0.2pp	98.5%+0.2pp	98.5%+0.5pp
Research and development	$1.05B+25.6%	$1.02B+38.9%	$943.1M+38.1%	$888.1M+40.9%	$834.9M+42.7%
Selling, general and administrative	$1.2B+15.1%	$1.16B+14.8%	$1.14B+21.7%	$1.08B+19.5%	$1.04B+17.2%
Total costs & expenses	$2.31B+20.6%	$2.24B+25.6%	$2.13B+28.2%	$2.01B+27.3%	$1.92B+26.4%
Operating income	$788.9M+59.4%	$619.1M+8.5%	$550.2M-4.9%	$495M-7.7%	$494.8M+6.5%
Operating margin	25.4%+4.9pp	21.6%-2.6pp	20.5%-5.3pp	19.7%-5.6pp	20.5%-2.9pp
Other income (expense), net	$148.6M—	$86.3M—	——	——	——
Income before income taxes	$937.5M+101%	$705.4M+45.1%	$628.6M+20.5%	$527.1M+17.9%	$466.2M-0.8%
Income tax expense	$268.9M+67.6%	$226.8M+56.7%	$200.6M+47.8%	$178.8M+66.0%	$160.4M+60.1%
Net income	$668.6M+119%	$478.6M+40.2%	$428M+10.9%	$348.3M+2.7%	$305.8M-17.3%
Net margin	21.6%+8.9pp	16.7%+2.2pp	16%-1.3pp	13.9%-2.1pp	12.7%-6.0pp
Diluted earnings per share	$6.49+120%	$4.66+41.6%	$4.18+11.5%	$3.38+1.5%	$2.95-19.2%
EBITDA	$818.7M+56.4%	$649.2M+8.6%	$579.9M-4.1%	$523.5M-6.7%	$523.3M+7.5%
EBITDA margin	26.4%+4.7pp	22.7%-2.7pp	21.6%-5.3pp	20.9%-5.6pp	21.7%-2.9pp
EBIT	$788.9M+59.4%	$619.1M+8.5%	$550.2M-4.9%	$495M-7.7%	$494.8M+6.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Neurocrine Biosciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's revenue?: Neurocrine Biosciences (NBIX) generated $3.1B in revenue over the trailing twelve months, up 28.6% year over year.
Is Neurocrine Biosciences profitable?: Neurocrine Biosciences reported $668.6M in net income over the trailing twelve months, a 21.6% net margin.
What are Neurocrine Biosciences's profit margins?: Gross margin is 98.2% and operating margin is 25.4%, with a 21.6% net margin.
What is Neurocrine Biosciences's earnings per share?: Neurocrine Biosciences's diluted EPS over the trailing twelve months is $6.49.
Where does Neurocrine Biosciences's income statement data come from?: Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.